diclofenac and pep005

diclofenac has been researched along with pep005 in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	21 (87.50)	24.3611
2020's	3 (12.50)	2.80

Authors

Authors	Studies
Gupta, AK; Paquet, M	1
Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N	1
Kemmett, D; Nasr, R; Smethurst, H; Thybo, S; Tolley, K	1
Isoherranen, K; Koskenmies, S; Overmark, M; Pitkänen, S; Saksela, O; Ylitalo, L	1
Erdmann, R; Jacobs, A; Nast, A; Rosumeck, S; Sporbeck, B; Werner, RN	1
Bottoni, U; Del Duca, E; Gliozzi, M; Muscoli, C; Nisticò, S; Torchia, V	1
Gilaberte, Y; González, S; Gracia-Cazaña, T	1
Athanasakis, K; Boubouchairopoulou, N; Kontodimas, S; Kyriopoulos, J; Tarantilis, F; Tsiantou, V	1
Holmstrup, H; Jemec, GBE; Malmberg, I; Norlin, JM; Norrlid, H; Ragnarson Tennvall, G; Sartorius, K; Thormann, H	1
Borkowska, JK; Czuwara, J; Damps, T; Konop, M; Kowalkowski, T; Laskowska, AK; Misicka, A; Prokopowicz, M; Puszko, AK; Różycki, K; Rudnicka, L; Sosnowski, P	1
Harwood, CA; Larsson, T; Serra-Guillén, C; Skov, T; Stockfleth, E; Østerdal, ML	2
Malvehy, J; Puig, S	1
Bagatin, E	1
da Motta, VRV; de Oliveira, ECV; Galadari, H; Ilha, CSO; Leonardi, GR; Magalhães, RF; Pantoja, PC	1
Bastian, M; Stockfleth, E	1
Almazan-Fernandez, FM; Husein-ElAhmed, H; Husein-ElAhmed, S	1
Calzavara-Pinton, P; Hamon, P; Tanova, N	1
Council, ML; Nemer, KM	1
Herms, F	1
Collins, A; Doerfler, L; Savas, J	1
Bastian, M; Hansen, JB; Larsson, T; Schmitz, L; Stockfleth, E	1
Arisi, M; Calzavara-Pinton, I; Calzavara-Pinton, PG; Caravello, S; Cozzi, C; Moggio, E; Polonioli, M; Rossi, MT; Soglia, S; Tomasi, C; Venturini, M; Zane, C	1
Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M	1

Reviews

8 review(s) available for diclofenac and pep005

Article	Year
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review. The British journal of dermatology, 2013, Volume: 169, Issue:2 Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome	2013
[Diagnosis and treatment of actinic keratosis]. Duodecim; laaketieteellinen aikakauskirja, 2015, Volume: 131, Issue:9 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Precancerous Conditions; Primary Health Care	2015
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments. Actas dermo-sifiliograficas, 2016, Volume: 107, Issue:9 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dermatologic Agents; Diclofenac; Diterpenes; Drug Resistance, Neoplasm; Fluorouracil; Humans; Imiquimod; Meta-Analysis as Topic; Neoplasm Proteins; Neoplastic Stem Cells; Skin Neoplasms	2016
Actinic keratosis - review for clinical practice. International journal of dermatology, 2019, Volume: 58, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Retinoids	2019
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis. Expert opinion on drug metabolism & toxicology, 2018, Volume: 14, Issue:9 Topics: Administration, Cutaneous; Animals; Apoptosis; Dermatologic Agents; Diclofenac; Diterpenes; Humans; Hyaluronic Acid; Keratosis, Actinic; Medication Adherence; Ultraviolet Rays	2018
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. Dermatologic clinics, 2019, Volume: 37, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms	2019
Nonsurgical Treatments for Nonmelanoma Skin Cancer. Dermatologic clinics, 2019, Volume: 37, Issue:4 Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting	2019
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies. The Australasian journal of dermatology, 2021, Volume: 62, Issue:2 Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms	2021

Trials

3 trial(s) available for diclofenac and pep005

Article	Year
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp. The British journal of dermatology, 2018, Volume: 178, Issue:2 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Diclofenac; Diterpenes; Drug Administration Schedule; Facial Dermatoses; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Scalp Dermatoses; Treatment Outcome	2018
Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment? The Journal of dermatological treatment, 2021, Volume: 32, Issue:4 Topics: Aged; Diclofenac; Diterpenes; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Treatment Outcome	2021
Effects of MAL-PDT, ingenol mebutate and diclofenac plus hyaluronate gel monitored by high-frequency ultrasound and digital dermoscopy in actinic keratosis - a randomized trial. Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:6 Topics: Aminolevulinic Acid; Dermoscopy; Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome	2020

Other Studies

13 other study(ies) available for diclofenac and pep005

Article	Year
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2013, Volume: 148, Issue:5 Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting	2013
A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective. The European journal of health economics : HEPAC : health economics in prevention and care, 2016, Volume: 17, Issue:3 Topics: Cost-Benefit Analysis; Cryotherapy; Diclofenac; Diterpenes; Dose-Response Relationship, Drug; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Models, Econometric; Quality-Adjusted Life Years; Recurrence; Salicylic Acid; Scotland; Treatment Outcome	2016
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:11 Topics: Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Curettage; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Photochemotherapy	2015
Pharmacoeconomy of drugs used in the treatment of actinic keratoses. International journal of immunopathology and pharmacology, 2016, Volume: 29, Issue:4 Topics: Cost-Benefit Analysis; Diclofenac; Diterpenes; Humans; Italy; Keratosis, Actinic; Quality of Life; Treatment Outcome	2016
Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece. Clinical therapeutics, 2017, Volume: 39, Issue:5 Topics: Aminoquinolines; Cost-Benefit Analysis; Diclofenac; Diterpenes; Greece; Humans; Imiquimod; Keratosis, Actinic; Quality-Adjusted Life Years	2017
Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients. The Journal of dermatological treatment, 2018, Volume: 29, Issue:1 Topics: Administration, Topical; Aged; Aminoquinolines; Denmark; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Quality of Life; Surveys and Questionnaires; Sweden	2018
The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment. PloS one, 2017, Volume: 12, Issue:8 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Diclofenac; Diterpenes; Fluorouracil; Humans; Keratinocytes; Protein Hydrolysates; Skin Neoplasms; Wool	2017
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp'. The British journal of dermatology, 2018, Volume: 178, Issue:3 Topics: Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Scalp	2018
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authors. The British journal of dermatology, 2018, Volume: 178, Issue:3 Topics: Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Scalp	2018
Treating actinic keratosis: assessment of effectiveness, discomfort, costs and follow-up. The British journal of dermatology, 2018, Volume: 178, Issue:2 Topics: Diclofenac; Diterpenes; Follow-Up Studies; Humans; Keratosis, Actinic; Scalp	2018
Ingenol mebutate versus imiquimod versus diclofenac for actinic cheilitis: a 6-month follow-up clinical study. Clinical and experimental dermatology, 2019, Volume: 44, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cheilitis; Diclofenac; Diterpenes; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged	2019
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:2 Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome	2019
Annales de dermatologie et de venereologie, 2019, Volume: 146 Suppl 2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cost-Benefit Analysis; Cryotherapy; Dermatologic Agents; Diclofenac; Diterpenes; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy	2019

chemdatabank.com